Open AccessS134: INTRA‐PATIENT FUNCTIONAL HETEROGENEITY OF AML DETERMINES FIRST‐LINE TREATMENT RESPONSE
Author(s) -
Severin Y.,
Festl Y.,
Roiss M.,
Benoit T.,
Heinemann T.,
Wegmann R.,
Kienzler A.K.,
Bissig M.,
Scharl M.,
Manz M.,
Müller A. M.,
Snijder B.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843428.60065.e6
Subject(s) - myeloid leukemia , medicine , oncology , bone marrow , stem cell , myeloid , population , haematopoiesis , clinical trial , biology , genetics , environmental health